top of page
This Month in DACH Startups - October 2025 | Deep Dive
Europe’s startup ecosystem is heating up again—smart capital is flowing into climate, deeptech, and infrastructure-heavy AI. In this month’s Top News episode, we cover €150m for Terra One, JPMorgan’s fintech push into Germany, Cutiss’ €57M biotech milestone, and a €3B fusion bet by Berlin. With new momentum in regulation, capital, and commercialization, the DACH region is setting the pace for pragmatic innovation. Welcome back to the serious side of tech.
Jörn Menninger
Nov 3, 202528 min read
Europe’s AI Supercluster: How DACH Startups Are Outpacing Silicon Valley
Europe’s startup ecosystem is heating up again—smart capital is flowing into climate, deeptech, and infrastructure-heavy AI. In this month’s Top News episode, we cover €150m for Terra One, JPMorgan’s fintech push into Germany, Cutiss’ €57M biotech milestone, and a €3B fusion bet by Berlin. With new momentum in regulation, capital, and commercialization, the DACH region is setting the pace for pragmatic innovation. Welcome back to the serious side of tech.
Jörn Menninger
Oct 30, 202527 min read
DACH Startup News September 2025: Deep Dive Into Ecosystem Trends
Europe’s startup ecosystem is heating up again—smart capital is flowing into climate, deeptech, and infrastructure-heavy AI. In this month’s Top News episode, we cover €150m for Terra One, JPMorgan’s fintech push into Germany, Cutiss’ €57M biotech milestone, and a €3B fusion bet by Berlin. With new momentum in regulation, capital, and commercialization, the DACH region is setting the pace for pragmatic innovation. Welcome back to the serious side of tech.
Jörn Menninger
Oct 6, 202531 min read
DACH Startup News September 2025: Top Founders, Funding and Policy Updates
Europe’s startup ecosystem is heating up again—smart capital is flowing into climate, deeptech, and infrastructure-heavy AI. In this month’s Top News episode, we cover €150m for Terra One, JPMorgan’s fintech push into Germany, Cutiss’ €57M biotech milestone, and a €3B fusion bet by Berlin. With new momentum in regulation, capital, and commercialization, the DACH region is setting the pace for pragmatic innovation. Welcome back to the serious side of tech.
Jörn Menninger
Oct 2, 202521 min read
Biotech Startup Funding: Annick Verween on Scaling Innovation in Europe
Biotech Startup Secrets: Funding, Scaling & Innovation Insights from Biotope's Annick Verween. Must-read for founders & investors!
Jörn Menninger
Apr 17, 202530 min read
Biotech Innovation Trends: Shaping the Future of Healthcare
Discover biotech's future! 🧬 Explore gene editing, immunotherapy, AI & more. See how these trends are transforming healthcare.
Jörn Menninger
Mar 19, 20254 min read
University Spin-Offs: Driving Biotech Innovation in Germany
Biotech spin-offs: 🧬 Discover their vital role in Germany's innovation ecosystem. Learn the process, challenges & opportunities!
Jörn Menninger
Mar 18, 20257 min read
Funding the Future: A Deep Dive into Biotech Startup Funding in Germany
Funding biotech in Germany? 🧬 Learn key strategies, VC insights, & govt programs. Get expert advice for startup success!
Jörn Menninger
Mar 17, 20256 min read
From Lab to Nasdaq: The Qiagen Founder: Stories and Lessons in Biotech Entrepreneurship
Qiagen's rise: From lab to Nasdaq. Biotech pioneer Riesner reveals key startup lessons. Read now!"
Jörn Menninger
Mar 13, 202556 min read
German Business Angel Day 2024: Insights from Mainz’s Premier Startup Event
Discover German Business Angel Day 2024 insights: AI surgical planning, sustainable construction, and biotech innovations redefining industr
Jörn Menninger
Jan 23, 202519 min read
Etalytics: Transforming Energy Management with AI Solutions
Discover how Etalytics revolutionizes energy management with AI, optimizing efficiency for data centers, pharma, and automotive.
Jörn Menninger
Nov 21, 202430 min read
Exclusive Insights From MIT's Robert Langer on Biotech Startups. Biotech Innovation and Modern Medicine Breakthroughs
Join Startuprad.io's Jörn Menninger as he interviews biotech pioneer Prof. Robert Langer on the future of mRNA tech and startup success.
Jörn Menninger
Aug 15, 202417 min read
Shoutout: "Startups from Science" Host Bartosz Kajdas at Curios 2024
Executive Summary In this episode of Startuprad.io, host Jörn "Joe" Menninger interviews Bartosz Kajdas, founder of the podcast "STARTUPS FROM SCIENCE." They discuss their presence at Curios 2024 in Mainz, where Bartosz is interviewing startups in the BioTech and Life Science sectors. Bartosz shares his background, having worked in innovation transfer at the University of Heidelberg and the Technical University Darmstadt for ten years. He highlights his podcast, which is avai
Jörn Menninger
Jul 29, 20247 min read
DACH Startup News April 2024: Founders, Funding and Ecosystem Updates
€1B biotech exit, Volocopter funding & Berlin’s fintech boom — April 2024 startup news in 30 mins or less 🚀
Jörn Menninger
Apr 24, 202447 min read
From Doctor to Entrepreneur Shaping the Future of Stem Cell Transplants
Andrea is the co-founder of Actitrex, a biotech startup focusing on immune cell therapy
Juan Diego Parra Castillo
Feb 8, 202421 min read
ENGLISH WORLD PREMIERE: The City of Mainz Just Started on Its Way to Becoming a World-Class BioTech Hub
Mainz's ambition to become a leading biotech hub is revealed in this exclusive interview with Felix Wälder. A world premiere in English!
Juan Diego Parra Castillo
Apr 5, 20224 min read
Meet Twin Brother Billionaires Behind BioNTech’s Success
Meet Andreas and Thomas Strüngmann, the twin billionaires behind BioNTech's success and the German biotech startup revolution.
Juan Diego Parra Castillo
Aug 9, 20218 min read
Meet the Startup NanoStruct, They Are Listening to Molecules
Meet NanoStruct, a startup enhancing spectroscopy with nanostructures for reliable biotech, pharma, and food industry applications.
Juan Diego Parra Castillo
Jun 2, 202116 min read
Looking back at the Corona Year — Rhine-Main Raised More Than One Billion US$
Rhine-Main startups raised 1.12 bn US$ in 2020. BioNTech's funding led the surge, driving investments in biotech during the pandemic.
Juan Diego Parra Castillo
Dec 31, 20205 min read
bottom of page